Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bifeprunox and Valproate Interaction in Bipolar I Disorder
NCT00141505Phase 2Completed
- Sponsor
- Solvay
- Start
- Feb 2005
- Primary completion
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of bifeprunox in bipolar I disorder, sponsored by Solvay. Primary endpoint: Pharmacokinetics of Valproate. Started Feb 2005; status: completed.
02
Drugs
bifeprunox
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT00141505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00141505.